Virtual simulation models can help identify the best ways to use different modalities to improve patient care during the pandemic.
CT scans and X-ray images can be safely tested and optimized with virtual imaging trials, newly published research shows.
In an article published ahead-of-print in the American Journal of Roentgenology, investigators from Duke University outlined how virtual imaging – using computational models to emulate imaging – can be used to improve care of patients with COVID-19. This virtual framework, they said, can shed light on how varying modalities can best be used during the outbreak.
“Virtual imaging trials are highly advantageous in that the same subjects can be imaged with different scanners and settings,” wrote the team led by Ehsan Abadi, Ph.D., assistant professor of radiology at Duke, “and the exact truth of the anatomic and physiologic features of the subjects are a priori known.”
According to the team, these virtual trials, also called virtual clinical trials or in silico trials, emulate imaging experiments by combining validated imaging simulators with computational models of patients. With COVID-19 in particular, Abadi’s team said the goal is to use these trials to compare CT and X-ray methods and identify protocols that can improve screening and follow-up, as well as dose optimization, for patients infected with the virus.
Using 4D extension cardio-torso models developed at Duke to which they added abnormalities associated with COVID-19 that were pulled from 20 CT scans of actual patients infected with the virus, including ground-glass opacities and consolidation, the team created computational patients. They constructed three different simulation models that could be imaged with either a CT or X-ray simulation tool also developed at Duke.
Based on subjective feedback to their work, the team reported that the simulated abnormalities in the models were realistic in shape and texture. Consequently, they determined, these tools sets could be used effectively in virtual imaging trials that can comprehensively assess and compare quality and performance of imaging methods with COVID-19 infection.
In addition, they said, these models can also be used to optimize radiation and image quality for each modality, as well as train and evaluate machine-learning algorithms for particular diseases.